(Q37967364)

26 August 2017

0 references

Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials (English)

1 reference

26 August 2017

0 references

0 references

1 reference

Catherine L Tacon

1

1 reference

26 August 2017

John McCaffrey

series ordinal

2

1 reference

26 August 2017

Anthony Delaney

series ordinal

3

1 reference

26 August 2017

publication date

8 December 2011

1 reference

26 August 2017

published in

Intensive Care Medicine

1 reference

26 August 2017

volume

38

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

359-367

1 reference

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Inotropes in cardiac patients: update 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Double-blind placebo-controlled comparison of enoximone and dobutamine infusions in patients with moderate to severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Inotropes in the management of acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Pharmacokinetics and pharmacodynamics of intravenous inotropic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Underreporting research is scientific misconduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2435-6

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

21 January 2018

1 reference

12 December 2020

Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance

1 reference

12 December 2020

Acute heart failure in the intensive care unit: epidemiology

1 reference

12 December 2020

Drug-induced conditioning in congestive heart failure

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models

1 reference

12 December 2020

Current drugs and medical treatment algorithms in the management of acute decompensated heart failure

1 reference

12 December 2020

Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial

1 reference

12 December 2020

Publication bias is a scientific problem with adverse ethical outcomes: the case for a section for null results

1 reference

12 December 2020

Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure

1 reference

12 December 2020

Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE

1 reference

12 December 2020

Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)

1 reference

12 December 2020

10.1007/S00134-011-2435-6

Identifiers

DOI

1 reference

26 August 2017

1 reference